
SURMOUNT Clinical Trials Orals Session
In this medfyle
3-year data from the SURMOUNT-1 trial explore T2D prevention in a subgroup with prediabetes at baseline, with results showing improvements in glycemia alongside weight, cardiometabolic factors, and quality of life.
About this Medfyle
©2024 Medfyle. All rights reserved.
Source: Perreault L, Jastreboff A, Wharton S, et al. SURMOUNT Clinical Trials Orals Session. Presented at ObesityWeek® 2024.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.